Adrian W Quartel insider trades

Open-market stock purchases and sales by Adrian W Quartel, Chief Medical Officer at Spruce Biosciences, Inc, from SEC Form 4 filings since Feb 21, 2022.

Recent trades

DateStockTradeValue
Jul 27, 2026SPRB Spruce Biosciences, IncBought (not open market)—
Jan 30, 2026ZVRA Zevra Therapeutics, IncSold$40K
Jan 30, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Jan 29, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Jan 29, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—

Companies traded

  • SPRB Spruce Biosciences, Inc: other filings, last Jul 27, 2026
  • ZVRA Zevra Therapeutics, Inc: 1 sale, last Jan 30, 2026
  • ACER Acer Therapeutics Inc: other filings, last Mar 14, 2023

Get free alerts when Adrian W Quartel files a new trade →